Actively Recruiting

Age: 18Years +
All Genders
NCT05587439

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

Led by Dana-Farber Cancer Institute · Updated on 2025-07-10

500

Participants Needed

2

Research Sites

252 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this research study is to learn more about the inherited risk for developing lung cancer.

CONDITIONS

Official Title

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with or at high risk of carrying an EGFR T790M or other EGFR germline variant identified in blood or saliva, including probands and family members
  • Individuals with or at high risk of carrying non-EGFR germline variants suggestive of inherited lung cancer risk, including probands and family members
  • Individuals with lung cancer not known to carry pathogenic variants but with one or more of: first-degree relative with lung cancer, multi-generational family history of lung cancer, personal history of multiple primary lung cancers or other cancers, or multifocal lung cancer
  • Blood relatives of individuals with the above variants or family history, including presumed carriers or healthy controls
  • Deceased patients may be included if consent is obtained from next-of-kin and relevant records or specimens are available
  • Data and specimens from previously consented eligible individuals may be included if consent permits sharing
  • Participants with variants of uncertain significance may be eligible at the principal investigator's discretion
Not Eligible

You will not qualify if you...

  • Individuals who decline to consent
  • Individuals unable to give consent or assent without a designated healthcare proxy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

2

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

J

Jaclyn LoPiccolo, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here